201 related articles for article (PubMed ID: 27575879)
21. Development of transdermal therapeutic formulation of CNS5161, a novel NMDA receptor antagonist, by utilizing pressure-sensitive adhesives II: improved transdermal absorption and evaluation of efficacy and safety.
Naruse M; Ogawara K; Kimura T; Konishi R; Higaki K
Eur J Pharm Sci; 2014 Feb; 52():86-94. PubMed ID: 24215737
[TBL] [Abstract][Full Text] [Related]
22. Probing the role of chemical enhancers in facilitating drug release from patches: Mechanistic insights based on FT-IR spectroscopy, molecular modeling and thermal analysis.
Song W; Quan P; Li S; Liu C; Lv S; Zhao Y; Fang L
J Control Release; 2016 Apr; 227():13-22. PubMed ID: 26896738
[TBL] [Abstract][Full Text] [Related]
23. Investigation on the effect of deep eutectic formation on drug-polymer miscibility and skin permeability of rotigotine drug-in-adhesive patch.
Liu C; Qu X; Song L; Shang R; Wan X; Fang L
Int J Pharm; 2020 Jan; 574():118852. PubMed ID: 31759103
[TBL] [Abstract][Full Text] [Related]
24. Role of pressure-sensitive adhesives in transdermal drug delivery systems.
Lobo S; Sachdeva S; Goswami T
Ther Deliv; 2016; 7(1):33-48. PubMed ID: 26652621
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in transdermal drug delivery.
Subedi RK; Oh SY; Chun MK; Choi HK
Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
[TBL] [Abstract][Full Text] [Related]
26. Realizing zero-order controlled transdermal drug permeation through competing doubly ionic H-bond in patch.
Zhang S; Zhang Q; Xu R; Ma J; Fang L
Int J Pharm; 2023 Oct; 645():123410. PubMed ID: 37703958
[TBL] [Abstract][Full Text] [Related]
27. Design of a tulobuterol patch with improved mechanical properties: effect of transdermal permeation enhancers on the release process of metal ligand-based acrylic pressure-sensitive adhesives.
Nan L; Song H; Wang H; Mi R; Wang X; Fang L
Drug Deliv Transl Res; 2024 Mar; 14(3):802-811. PubMed ID: 38082031
[TBL] [Abstract][Full Text] [Related]
28. Effect of vehicles and pressure sensitive adhesives on the permeation of tacrine across hairless mouse skin.
Kim J; Cho Y; Choi H
Int J Pharm; 2000 Feb; 196(1):105-13. PubMed ID: 10675712
[TBL] [Abstract][Full Text] [Related]
29. Investigation of molecular mobility of pressure-sensitive-adhesive in oxybutynin patch in vitro and in vivo: Effect of sorbitan monooleate on drug release and patch mechanical property.
Wang W; Liu C; Luo Z; Wan X; Fang L
Eur J Pharm Sci; 2018 Sep; 122():116-124. PubMed ID: 29928984
[TBL] [Abstract][Full Text] [Related]
30. A strong, silk protein-inspired tissue adhesive with an enhanced drug release mechanism for transdermal drug delivery.
Song H; Wang L; Wu J; Liu J; Liu C; Guo J; Fang L
Acta Biomater; 2024 Jun; 181():133-145. PubMed ID: 38641185
[TBL] [Abstract][Full Text] [Related]
31. Probing the mechanism of release process from metal coordination-based acrylic pressure-sensitive adhesives: Synergistic effect of coordination and hydrogen bonding for controlled drug release.
Nan L; Liu C; Song H; Wang X; Wang P; Fang L
Int J Pharm; 2024 Jan; 649():123575. PubMed ID: 37926177
[TBL] [Abstract][Full Text] [Related]
32. Development and evaluation of a drug-in-adhesive transdermal delivery system for delivery of olanzapine.
Vora D; Banga AK
Expert Opin Drug Deliv; 2022 Nov; 19(11):1539-1548. PubMed ID: 36242524
[TBL] [Abstract][Full Text] [Related]
33. Mechanistic insights of the enhancement effect of sorbitan monooleate on olanzapine transdermal patch both in release and percutaneous absorption processes.
Li N; Quan P; Wan X; Liu C; Liu X; Fang L
Eur J Pharm Sci; 2017 Sep; 107():138-147. PubMed ID: 28693956
[TBL] [Abstract][Full Text] [Related]
34. A molecular mechanism investigation of the transdermal/topical absorption classification system on the basis of drug skin permeation and skin retention.
Tian Q; Quan P; Fang L; Xu H; Liu C
Int J Pharm; 2021 Oct; 608():121082. PubMed ID: 34506925
[TBL] [Abstract][Full Text] [Related]
35. Development of a Predictive Model for the Stabilizer Concentration Estimation in Microreservoir Transdermal Drug Delivery Systems Using Lipophilic Pressure-Sensitive Adhesives as Matrix/Carrier.
Chenevas-Paule C; Wolff HM; Ashton M; Schubert M; Dodou K
J Pharm Sci; 2017 May; 106(5):1371-1383. PubMed ID: 28163134
[TBL] [Abstract][Full Text] [Related]
36. Investigate the control release effect of ion-pair in the development of escitalopram transdermal patch using FT-IR spectroscopy, molecular modeling and thermal analysis.
Wang W; Song T; Wan X; Liu C; Zhao H; Fang L
Int J Pharm; 2017 Aug; 529(1-2):391-400. PubMed ID: 28673858
[TBL] [Abstract][Full Text] [Related]
37. Release and Skin Permeation of Scopolamine From Thin Polymer Films in Relation to Thermodynamic Activity.
Kunst A; Lee G
J Pharm Sci; 2016 Apr; 105(4):1496-500. PubMed ID: 27019963
[TBL] [Abstract][Full Text] [Related]
38. Development of transdermal therapeutic formulation of CNS5161, a novel N-methyl-D-aspartate receptor antagonist, by utilizing pressure-sensitive adhesives I.
Naruse M; Ogawara K; Kimura T; Konishi R; Higaki K
Biol Pharm Bull; 2012; 35(3):321-8. PubMed ID: 22382317
[TBL] [Abstract][Full Text] [Related]
39. In vitro efficacy and release study with anti-inflammatory drugs incorporated in adhesive transdermal drug delivery systems.
Meyer S; Peters N; Mann T; Wolber R; Pörtner R; Nierle J
J Pharm Sci; 2014 Apr; 103(4):1142-8. PubMed ID: 24633817
[TBL] [Abstract][Full Text] [Related]
40. Controlled transdermal delivery of model drug compounds by MEMS microneedle array.
Xie Y; Xu B; Gao Y
Nanomedicine; 2005 Jun; 1(2):184-90. PubMed ID: 17292077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
